Remove Clinical Development Remove Organic Chemistry Remove Protein Expression Remove Therapies
article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

Christopher Rowley, PhD, Principal Research Scientist, Protein Science Pipeline, Immunocore, on: ‘ImmTAC: A high-affinity soluble TCR bispecific platform to target cancers’. Jürgen Kuball, PhD, Head, Hematology, University Medical Center Utrecht, on: ‘gdT cell inspired therapies’.